Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results
Financial Performance: Natural Alternatives International, Inc. reported a net loss of $1.9 million for Q4 2024, with total sales decreasing by 18% to $29.5 million compared to the previous year, leading to an annual net loss of $7.2 million.
Future Outlook: Despite recent losses, the company anticipates improved sales in fiscal 2025, projecting a net loss in the first half but expecting profitability in the second half, bolstered by new business opportunities and product introductions like their TriBsyn™ ingredient.
Trade with 70% Backtested Accuracy
Analyst Views on NAII
About NAII
About the author
Natural Alternatives International, Inc. Reports Q4 and Year-to-Date Results for Fiscal Year 2025
Financial Performance: Natural Alternatives International, Inc. reported a net loss of $7.2 million for Q4 FY 2025, compared to a loss of $1.9 million in the same quarter of the previous year, with net sales increasing by 15% to $33.9 million.
Annual Overview: For the fiscal year 2025, the company experienced a net loss of $13.6 million, up from $7.2 million in FY 2024, despite a 14% increase in annual net sales to $129.9 million.
Future Outlook: The company anticipates a net loss in the first half of FY 2026 but expects to achieve profitability in the second half, driven by growth in customer relationships and sales.
Operational Challenges: The net loss was attributed to underutilization of factory capacity, a valuation allowance against deferred tax assets, and litigation settlement costs, despite overall revenue growth.
Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company
Partnership Extension: Natural Alternatives International, Inc. has extended its partnership with The Juice Plus+ Company through a new multi-year Manufacturing Agreement for their capsule and powder products sold globally.
Commitment to Quality: Both companies emphasize their long-standing relationship and commitment to delivering high-quality nutritional products backed by scientific research, aiming for mutual benefits from the contract extension.